PNEUMOCOCCAL INFECTIONS
Clinical trials for PNEUMOCOCCAL INFECTIONS explained in plain language.
Never miss a new study
Get alerted when new PNEUMOCOCCAL INFECTIONS trials appear
Sign up with your email to follow new studies for PNEUMOCOCCAL INFECTIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaccine aims to shield infants from deadly pneumonia
⭐️ VACCINE ⭐️ OngoingThis study tests a new vaccine to protect babies against pneumococcal infections, which can cause pneumonia and meningitis. About 600 healthy infants in Thailand will receive either the new or a standard vaccine at 2, 4, and 12-15 months old. Researchers will check how well the v…
Matched conditions: PNEUMOCOCCAL INFECTIONS
Phase: PHASE3 • Sponsor: CanSino Biologics Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Aug 07, 2026 00:00 UTC
-
New vaccine aims to protect kids from pneumonia – study underway
⭐️ VACCINE ⭐️ OngoingThis study tests a new 21-valent pneumococcal vaccine (PCV21) in healthy infants, toddlers, children, and adolescents who need catch-up vaccination. Around 1,268 participants will receive either PCV21 or the current 20-valent vaccine. Researchers will monitor side effects and mea…
Matched conditions: PNEUMOCOCCAL INFECTIONS
Phase: PHASE3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 07:53 UTC